Article ID Journal Published Year Pages File Type
6216578 Journal of Pediatric Surgery 2016 4 Pages PDF
Abstract

BackgroundOutcomes of children with intestinal failure have improved over the last decade. However, with improved survival, other co-morbidities have become evident. The goal of our study was to evaluate the presence of renal nephrocalcinosis or increased echogenicity in a cohort of patients with pediatric intestinal failure (PIF).MethodsA cross-sectional prevalence design was performed in PIF patients followed by our intestinal rehabilitation program between 2013 and 2014. Renal function was evaluated using serum creatinine and urea, urine oxalate, creatinine, calcium, and calcium/creatinine ratios. Renal ultrasounds were performed to assess for echogenicity. Data was collected on intestinal failure related factors and nutritional intake. Data was analyzed using medians and Mann-Whitney U or proportions and chi square.ResultsFifty-four patients (median age 48 months; 33 males (61%) were studied. Twenty-two patients (41%) had increased echogenicity or nephrocalcinosis on ultrasound. There were no differences in serum Creatinine or urea, but patients with nephrocalcinosis had statistically different calcium:creatinine ratio (1.69 vs 0.74; p = 0.043), urine oxalate (108 vs 219; p = 0.06), and serum phosphate (1.55 vs 1.75; p = 0.044). Patients with echogenicity had a shorter colonic remnant (25 cm vs 31 cm; p = 0.01), a history of longer PN exposure (928 vs 483 days; p = 0.05), percent PN calories (37 vs 0; p = 0.05), PN h/day (13 vs 0; p = 0.05), but no difference in PN Ca/phosphate/magnesium content (mmol/kg).ConclusionA large proportion of PIF patients have increased echogenicity/nephrocalcinosis on ultrasound that is associated with prolonged PN exposure. This has implications for long-term management. Regular surveillance is required, and further study is warranted to determine specific risk factors.

Related Topics
Health Sciences Medicine and Dentistry Perinatology, Pediatrics and Child Health
Authors
, , , , , , , , ,